Navigation Links
Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings

NEWTON, Mass.--(BUSINESS WIRE)--Jul 9, 2007 - Pro-Pharmaceuticals, Inc. (Amex: PRW), a company "Advancing Drugs Through Glycoscience(R)", today updated the progress of its Phase II clinical trial for first-line treatment of metastatic, unresectable colorectal cancer patients who are unable to tolerate irinotecan and/or oxaliplatin, and its Phase II clinical trial for first-line treatment of biliary cancer patients. Treatment for both indications may represent orphan drug status for DAVANAT(R), the Company's target delivery compound. In addition, the Company plans to submit the manufacturing data requested by the FDA this year for DAVANAT(R) 505 (b)(2) filings as a functional excipient.

Phase II, First Line Treatment, Colorectal Cancer Trial

To date, eight patients have been dosed with DAVANAT(R) in combination with 5-FU, Avastin(R) and leucovorin. Two patients have tumor shrinkage of greater than 30%, a partial response according to Response Evaluation Criteria for Solid Tumors (RECIST). Five patients have stable disease for up to seven months and one had non-drug related progressive disease. Patients experienced no increase in drug-related toxicity and reduced side effects with increased exposure to 5-FU and AVASTIN(R). The Simon two-stage designed study is an open-label, multi-center trial. The primary objectives of the trial are tumor shrinkage and progression-free survival. Six sites are actively recruiting patients. Additional sites are expected to be active shortly. Nine of 25 (36%) end-stage colorectal cancer patients from Phase I/II trials were stabilized from 2 to 8 months.

Phase II, First Line Treatment, Biliary Cancer Trial

To date, seven patients have been dosed with DAVANAT(R) in combination with 5-FU. One patient has tumor shrinkage of greater than 30%, a partial response according to RECIST. Five patients have stable disease for up to five months and one had non-drug related
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Pro-Pharmaceuticals to Present Abstract at the International Society of Oncodevelopmental Biology and Medicine Conference
2. Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
3. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
4. NCCN Updates Esophageal and Gastric Cancer Guidelines
5. Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients
6. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
7. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Biodel Inc. to Present VIAject Clinical Progress at the 2007 American Diabetes Association Meeting
10. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
11. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
Post Your Comments:
(Date:8/29/2014)... Ore. , Aug. 29, 2014 /PRNewswire-iReach/ -- ... Accessory (Axilla) Strap for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today ... voluntary recall to address a potential issue with ... used for the Axilla application of the SAM ...
(Date:8/29/2014)... PLEASANTON, Calif. , Aug. 29, 2014 ... leader in device-based mechanical circulatory support therapies to save, ... be participating in the 2014 Morgan Stanley Global Healthcare ... F. Burbach , President and Chief Executive Officer, will ... p.m., Eastern Daylight Time (9:55 a.m., Pacific Daylight Time). ...
(Date:8/29/2014)... , August 29, 2014 ... Oil Market by Extraction type (SFE, Cold Pressed, ... Personal Care, Pharmaceutical, Food Supplements, Fragrance, & Others) - ... MarketsandMarkets, defines and segments the Amaranth Seed Oil ... market size in terms of value. The Amaranth ...
Breaking Medicine Technology:SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... The two most,prevalent forms of genetic mental retardation, ... cause, according to researchers at,Stanford University School of ... brain, may also be associated with,autism., Although the ... result for the brain seems to be the ...
... YORK--(BUSINESS WIRE)--Apr 12, 2007 - INNOVIVE Pharmaceuticals,Inc. ... of INNO-406, a potent oral dual Bcr-Abl ... leukemia, will be presented at the American ... takes place April,14-18, 2007 at the Los ...
Cached Medicine Technology:Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 2Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 3Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 4Innovive Pharmaceuticals Announces Additional Data Presentations at,American Association for Cancer Research Annual Meeting 2
(Date:8/30/2014)... A new batteryless cardiac pacemaker based on an ... presented at ESC Congress 2014 today by Adrian ... require battery replacement. , Mr Zurbuchen, a PhD ... University of Bern, Switzerland, said: "Batteries are a ... reach a critically low energy level, physicians see ...
(Date:8/30/2014)... Malden, MA (PRWEB) August 31, 2014 In ... ‘dog eat dog’ approach, Karma Web Group, LLC launches a ... iOS and Android the newly launched Ultimate Karma app is ... rewarded with new levels of play, the game pulls double-duty ... at the same time. , Designed to reward gamers for ...
(Date:8/30/2014)... Atlanta, GA (PRWEB) August 31, 2014 ... across their dealerships to help raise money and awareness ... Bucket Challenge. , General Managers, staff, and even Vice ... was captured on film and can be viewed on ... to participating in the challenge, general managers and staff ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 The Truth about ... body that will reveal to users some shocking foods that ... great results in modeling looks, as well as some motivation ... method says that there is one unique trick that can ... indicates that despite what many people might think, cardio exercise ...
(Date:8/30/2014)... 2014 Ticket Down reports that ticket ... match next Saturday at Levi's Stadium. The summer months ... in the United States due to the fact that so many ... major city. Many of these games were practice games in ... summer. , Levi’s Stadium is a brand new facility that will ...
Breaking Medicine News(10 mins):Health News:Batteryless cardiac pacemaker is based on automatic wristwatch 2Health News:Newly Launched Ultimate Karma App Elicits Happiness in Players and Encourages Moral Values 2Health News:Jim Ellis Automotive Group Take the ALS Ice Bucket Challenge 2Health News:Truth about Six Pack Abs Review Reveals Unique Method to Eliminate Stubborn Stomach Fat 2Health News:Mexico vs. Chile Tickets at Levi's Stadium in Santa Clara, CA: TicketDown.com Offers Promo Code for Mexico vs. Chile Exhibition Game on September 6th 2
... Survey Reveals Favorite and Least Favorite Body Parts: ... Jan. 21 Faces and abs top the list ... both men and women, according to a new survey ... non-invasive aesthetic services in the U.S.Nearly a quarter of ...
... for 2009 , ... (Vocus) January 21, 2009 -- ... 2009 according to recent predictions made by the leadership of the ... prediction: a continued growth in consumers who elect to enhance ...
... Jan. 21 Senator Sam Brownback and Rep. ... Council,s Blogs for Life, on ... also feature several prominent conservative voices including Amanda ... Ph.D., Michael Illions, Peter Shinn, Chris Gacek, J.D., ...
... Health Plan Outperforms National Medicaid Plans on Key ... Health Plan (SFHP), the City,s community health plan, ... U.S. leader in childhood immunizations for Medicaid health ... are fully immunized, besting second-ranked Kaiser Permanente of ...
... have different reproductive plans, lifestyles, religious prohibitions, and ... contraceptive choices available, can make selecting the right ... of appropriate and acceptable contraceptive methods can improve ... pregnancy. To address this issue, OBG Management ...
... BALTIMORE, Jan. 21 Physicians Practice and Tucson Medical ... and their staff more time to devote to patient ... to help doctors in the southern Arizona area better ... busy practice. Through this new alliance, Tucson Medical Center ...
Cached Medicine News:Health News:How Does Our Vanity Fare? 2Health News:Cosmetic Injections A Worthwhile Investment 2Health News:Cosmetic Injections A Worthwhile Investment 3Health News:Cosmetic Injections A Worthwhile Investment 4Health News:Senator Sam Brownback and Rep. Cathy McMorris Rodgers to Speak at Blogs for Life 2009 2Health News:San Francisco Health Plan is U.S. Leader in Childhood Immunizations 2Health News:San Francisco Health Plan is U.S. Leader in Childhood Immunizations 3Health News:Physicians Practice and Tucson Medical Center Partner to Improve Patient Care in Southern Arizona 2Health News:Physicians Practice and Tucson Medical Center Partner to Improve Patient Care in Southern Arizona 3
... single-use products to promote safety for your ... catheter reduces cross-contamination and helps protect your ... because cleaning is eliminated, you have more ... water perfused manometric catheters for esophageal, anorectal ...
Esophageal Stylet for LATITUDE® Air-Charged Catheter...
Replacement Stopper for LATITUDE® Air-Charged Catheter...
Manometric Calibration System for LATITUDE® Air-Charged Catheter...
Medicine Products: